- Home
- ALNY vs PWR Comparison
ALNY vs PWR Comparison
Compare ALNY & PWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALNY
- PWR
- Stock Information
- Founded
- ALNY 2002
- PWR 1997
- Country
- ALNY United States
- PWR United States
- Employees
- ALNY N/A
- PWR N/A
- Industry
- ALNY Biotechnology: Pharmaceutical Preparations
- PWR Engineering & Construction
- Sector
- ALNY Health Care
- PWR Industrials
- Exchange
- ALNY Nasdaq
- PWR Nasdaq
- Market Cap
- ALNY 60.7B
- PWR 65.1B
- IPO Year
- ALNY 2004
- PWR 1998
- Fundamental
- Price
- ALNY $463.36
- PWR $439.95
- Analyst Decision
- ALNY Strong Buy
- PWR Buy
- Analyst Count
- ALNY 27
- PWR 21
- Target Price
- ALNY $466.46
- PWR $406.68
- AVG Volume (30 Days)
- ALNY 1.0M
- PWR 1.0M
- Earning Date
- ALNY 10-30-2025
- PWR 10-30-2025
- Dividend Yield
- ALNY N/A
- PWR 0.09%
- EPS Growth
- ALNY N/A
- PWR 21.63
- EPS
- ALNY N/A
- PWR 6.44
- Revenue
- ALNY $2,461,963,000.00
- PWR $26,052,930,000.00
- Revenue This Year
- ALNY $60.04
- PWR $17.98
- Revenue Next Year
- ALNY $40.69
- PWR $12.12
- P/E Ratio
- ALNY N/A
- PWR $69.65
- Revenue Growth
- ALNY 5.01
- PWR 18.26
- 52 Week Low
- ALNY $205.87
- PWR $227.08
- 52 Week High
- ALNY $495.55
- PWR $459.36
- Technical
- Relative Strength Index (RSI)
- ALNY 49.33
- PWR 57.24
- Support Level
- ALNY $456.90
- PWR $433.88
- Resistance Level
- ALNY $485.36
- PWR $459.36
- Average True Range (ATR)
- ALNY 16.80
- PWR 13.85
- MACD
- ALNY -1.23
- PWR -0.45
- Stochastic Oscillator
- ALNY 33.70
- PWR 64.62
About ALNY Alnylam Pharmaceuticals Inc.
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia. It also has several clinical programs across various therapeutic areas: genetic medicines; cardio-metabolic diseases; hepatic infectious diseases, and CNS/ocular diseases. Upfront fees from research partnerships have boosted Alnylam's cash levels, and the company stands to see additional milestones and royalties from drugs commercialized under collaboration partnerships.
About PWR Quanta Services Inc.
Quanta Services is a leading provider of specialty contracting services, delivering comprehensive infrastructure solutions for the electric and gas utility, communications, pipeline, and energy industries in the United States, Canada, and Australia. Quanta reports its results under two segments: electric infrastructure and underground utility and infrastructure.